Extending survival for people with hepatitis C using tobacco dependence treatment
Sign Up to like & getrecommendations! Published in 2017 at "The Lancet"
DOI: 10.1016/s0140-6736(17)32460-1
Abstract: The availability of direct-acting antiviral (DAA) therapies for hepatitis C virus (HCV) has led WHO to advocate for the elimination of HCV. However, a 2017 Cochrane review suggests that DAA treatment might not improve morbidity… read more here.
Keywords: tobacco; tobacco dependence; treatment; living hcv ... See more keywords